Nancy Byatt, DO, MS, MBA

Careful consideration and discussion of risks of treatment and under-treatment (or no treatment) can help can decrease the risk of decompensation during pregnancy or the postpartum period.

This article summarizes clinically relevant advances in the psychiatric care of women during and after pregnancy, including recent changes in how the FDA classifies pregnancy risk for medications, and best practices in perinatal psychopharmacology.